RE:Adcom voting resultsGood Synopsis. The blatant black eye on this Adcomm was that 90% or more of the discussion was not anchored to the FDA/AUA trial standards. I heard more concern forbthenlacknof minoritiesbin the trial than I did regarding the revised trial standards and how MCNA performed relative to them!
On the few occasions the conversation could have headed that way it drifted off into irrelevance again. There was no anchor and no mooring. It could have been a Sunday morning conversation at a frat house for PHDs. Not entirely meaningless but of very little value relative to the real question at hand, the standard for approval and the relative merits of MCNA.